Mineral trioxide aggregate enhances the osteogenic capacity of periodontal ligament stem cells via NF‐κB and MAPK signaling pathways

Journal of Cellular Physiology - Tập 233 Số 3 - Trang 2386-2397 - 2018
Yanqiu Wang1, Yixiang Zhou2,1, Jin Lin1, Xiyao Pang1, Yadie Lu1, Zilu Wang1, Yu Yan1, Jinhua Yu1
1Key Laboratory of Oral Diseases of Jiangsu Province and Stomatological Institute of Nanjing Medical University, Nanjing, Jiangsu, China
2IVY Dental Clinic, Hangzhou, Zhejiang, China

Tóm tắt

Mineral trioxide aggregate (MTA), as a bioactive material, has a widespread application in clinical practice. To date, the effects of MTA on the proliferation and differentiation of human periodontal ligament stem cells (hPDLSCs) remain unclear. hPDLSCs were isolated from human periodontal ligament tissues and cultured with MTA conditioned media. Cell counting kit‐8 (CCK‐8) assay was performed to assess the proliferation capacity of MTA‐treated hPDLSCs. Immunofluorescence assay, alkaline phosphatase (ALP) activity, alizarin red staining, real‐time RT‐PCR, and western blot analyses were used to investigate the odonto/osteogenic capacity of hPDLSCs as well as the involvement of NF‐κB and MAPK pathways. ALP activity assay revealed that 2 mg/ml was the optimal concentration for the induction of hPDLSCs by MTA. The protein expression of DSP, RUNX2, OCN, OSX, OPN, DMP1, ALP, and COL‐I in MTA‐treated hPDLSCs was significantly higher than those in control group (p < 0.01). When hPDLSCs were treated with the inhibitors of NF‐κB and MAPK pathways (U0126, SP600125, SB203580, and BMS345541), the effects of MTA on the differentiation of hPDLSCs were suppressed. Mechanistically, P65 was detected to transfer from cytoplasm to nuclei, as indicated by western blot and immunofluorescence assay. Moreover, MAPK‐related proteins and its downstream transcription factors were also upregulated in MTA‐treated hPDLSCs. Together, mineral trioxide aggregate can promote the odonto/osteogenic capacity of hPDLSCs via activating the NF‐κB and MAPK pathways.

Từ khóa


Tài liệu tham khảo

10.1016/j.msec.2016.08.045

10.1007/s00441-010-1046-9

10.1158/0008-5472.CAN-13-1385

10.1074/jbc.M209677200

10.1111/j.1365-2184.2011.00780.x

Chan L. P., 2017, IL‐8 promotes inflammatory mediators and stimulates activation of p38 MAPK/ERK‐NF‐kappaB pathway and reduction of JNK in HNSCC, Oncotarget

10.1016/j.cbi.2010.01.040

10.1007/s11010-012-1336-5

10.1016/j.joen.2010.07.003

10.1002/jcp.22024

10.1159/000276589

10.1002/jcp.22050

10.1074/jbc.M112.445775

10.1016/j.joen.2008.11.006

10.22203/eCM.v032a15

10.1016/S1534-5807(02)00157-0

10.1016/j.bone.2005.10.026

10.1002/(SICI)1097-4636(19971205)37:3<432::AID-JBM14>3.0.CO;2-D

10.1016/j.joen.2013.06.030

10.1016/j.fct.2012.08.019

10.1074/jbc.275.10.7395

10.1177/0022034508328168

10.1016/j.joen.2010.04.027

10.1186/scrt515

10.1017/S0007114513002043

10.1016/j.archoralbio.2016.08.011

10.1177/154405910808701217

10.1186/1742-2094-8-6

10.1016/j.joen.2012.10.007

10.1016/j.joen.2008.03.009

Mohammadi Z., 2014, Mineral trioxide aggregate (MTA)‐like materials: An update review, Compendium of Continuing Education in Dentistry, 35, 557

Moradi S., 2016, Immunohistological evaluation of revascularized immature permanent necrotic teeth treated by platelet‐rich plasma: An animal investigation, Cell Journal, 18, 389

Narad P., 2016, Transcription factor information system (TFIS): a tool for detection of transcription factor binding sites, Interdisciplinary Sciences

10.3727/096368910X519292

10.1093/hmg/11.21.2559

10.1016/j.joen.2016.08.027

10.1016/j.joen.2015.07.015

10.1097/01.DON.0000133155.04468.41

10.1359/jbmr.060603

10.1016/S0140-6736(04)16627-0

10.1101/gad.845101

Tawil P. Z., 2015, Mineral trioxide aggregate (MTA): its history, composition, and clinical applications, Compendium of Continuing Education in Dentistry, 36, 247

10.1186/s12903-015-0117-4

10.1016/j.biocel.2006.07.001

van Heerden B., 2017, Palmitoleic acid inhibits RANKL‐Induced osteoclastogenesis and bone resorption by suppressing NF‐kappaB and MAPK signalling pathways, Nutrients, 9, 10.3390/nu9050441

10.1590/S1678-77572011005000019

10.1007/s00210-012-0740-4

10.1016/j.joen.2009.09.039

10.1111/cpr.12099

10.1111/odi.12183

10.1007/s00441-013-1604-z

10.1177/154405910808700509

10.4161/cbt.3.10.1141

10.1016/j.joen.2014.01.042

10.1016/j.joen.2008.06.007

10.1074/jbc.M400490200

10.1371/journal.pone.0055730

10.1007/s10753-015-0134-0

10.1155/2015/972313